Granulomatous Polyangiitis: Clinical Trials

1 trial for Granulomatous Polyangiitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow Granulomatous Polyangiitis: new trials by email Literature Review of Granulomatous Polyangiitis trials Research Report on Granulomatous Polyangiitis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE)
CD19- BCMA CAR-T cells - Systemic Lupus Erythematosus, Lupus Nephritis
Phase 1 / Phase 2RecruitingEssen Biotech752024-07-102024-10-15

Narrower conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1)  ·  Autoimmune Diseases (1)  ·  Granulomatosis with Polyangiitis (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Lupus Nephritis (1)  ·  Microscopic Polyangiitis (1)  ·  Myositis (1)  ·  Scleroderma, Systemic (1)  ·  Sjogren's Syndrome (1)

Broader conditions

Arthritis (1)  ·  Arthritis, Rheumatoid (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebral Small Vessel Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Connective Tissue Diseases (1)  ·  Dry Eye Syndromes (1)  ·  Eye Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glomerulonephritis (1)  ·  Immune System Diseases (1)  ·  Joint Diseases (1)

Sponsors

Essen Biotech (1)

Countries

China (1)